Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2020-05-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine (Carlsbad Technology, Inc.), resulting in changes to its labeling.
-
FDA approval · 2020-04-30FDA Approved: OMEPRAZOLE, SODIUM BICARBONATE — Original Application (Guardian Drug Company)
FDA approved Guardian Drug Company's original application for omeprazole sodium bicarbonate, a generic proton pump inhibitor combination, fo…
-
FDA approval · 2020-04-01FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Gland Pharma Limited)
FDA approved the original application for esomeprazole sodium (generic) from Gland Pharma Limited, enabling its marketing in the United Stat…
-
FDA approval · 2020-03-25FDA Approved: OMEPRAZOLE — Original Application (CHAIN DRUG MARKETING ASSOCIATION, INC.)
The FDA approves an original application for omeprazole (generic) submitted by Chain Drug Marketing Association, Inc., covering indications …
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for esomeprazole magnesium, a generic proton pump inhibitor.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s Esomeprazole Magnesium as a generic version of esomeprazole under an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2020-03-11Clinical Trial Update: Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"
A clinical trial update on vonoprazan for preventing recurrence of gastric/duodenal ulcers in patients on low-dose aspirin; study completed …
-
FDA approval · 2020-03-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Lifestar Pharma LLC.)
FDA approves a supplemental application to allow Lifestar Pharma LLC to market a generic version of lansoprazole.
-
FDA approval · 2020-02-21FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
The FDA approved a supplemental application for Walgreens' CIMETIDINE 200 ACID REDUCER, indicating approval of changes to the approved gener…
-
FDA label_change · 2020-01-07FDA Approved: FAMOTIDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA notes a supplemental application for famotidine by Lupin Pharmaceuticals, likely involving labeling changes for the drug.
-
FDA approval · 2020-01-03FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium from Lannett Company (ANDA 078281).
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"
A completed clinical trial update for vonoprazan assessing gastric ulcer, duodenal ulcer, and reflux esophagitis with results posted in 2019…
-
FDA approval · 2019-12-02FDA Approved: SUCRALFATE — Original Application (AvPAK)
FDA approved the original ANDA for sucralfate oral, enabling generic marketing by AvPAK.
-
FDA approval · 2019-11-29FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for Rabeprazole sodium by Advagen Pharma Limited.
-
FDA approval · 2019-11-15FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for Rabeprazole sodium from Amneal Pharmaceuticals LLC (ANDA 204179).
-
FDA approval · 2019-11-14FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium from Torrent Pharmaceuticals Limited.
-
FDA approval · 2019-10-22FDA Approved: ACID CONTROLLER — Supplemental Application (H E B)
The FDA approved a supplemental application for ACID CONTROLLER (famotidine) submitted by H E B.
-
FDA approval · 2019-10-22FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., indicating changes or additions to the approved …
-
FDA approval · 2019-10-22FDA Approved: FAMOTIDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for famotidine by Aurobindo Pharma Limited under an ANDA, extending approval to include this manufac…
-
FDA approval · 2019-09-26FDA Approved: OMEPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic omeprazole in an Original Abbreviated New Drug Application, authorizing its use for the same in…
-
FDA approval · 2019-09-24FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for OMEPRAZOLE AND SODIUM BICARBONATE (omeprazole and sodium bicarbonate) from Oceanside Pharmaceuti…
-
FDA approval · 2019-09-16FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC.
-
FDA approval · 2019-09-11FDA Approved: ZANTAC 360 — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for ZANTAC 360 (famotidine) from Chattem, Inc., updating the product under an approved supplemen…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy [Phase 4]
A Phase 4 trial comparing berberine-amoxicillin quadruple therapy to tetracycline-furazolidone quadruple therapy for Helicobacter pylori-rel…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer [Phase 3]
Phase 3 trial assessing safety and efficacy of CJ-12420 in patients with gastric ulcer has completed.